Nanoparticles from Actinobacteria: A Potential Target to Antimicrobial Therapy

Author(s): Palaniappan Sivasankar, Subramaniam Poongodi, Palaniappan Seedevi, Dharman Kalaimurugan, Murugesan Sivakumar, Sivakumar Loganathan*

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 24 , 2019


Become EABM
Become Reviewer
Call for Editor

Abstract:

Nanoparticles have gained significant importance in the past two decades, due to their multifaceted applications in the field of nanomedicine. As our ecosystems and habitats are changing due to global warming, many new diseases are emerging continuously. Treating these costs a lot of money and mostly ends up in failure. In addition, frequent use of antibiotics to control the emerging diseases has led the pathogens to develop resistance to antibiotics. Hence, the nanoparticles are targeted to treat such diseases instead of the costly antibiotics. In particular, the biosynthesized nanoparticles have received considerable attention due to their simple, eco-friendly and promising activity. To highlight, microbial mediated nanoparticles have been found to possess higher activity and thus have a promising role in antimicrobial therapy to fight against the emerging drug-resistant pathogens. In this context, this review article is aimed at highlight the role of nanoparticles in the field of nanomedicine and importance of actinobacteria in the nanoparticle synthesis and their need in antimicrobial therapy. This is a comprehensive review, focusing on the potential of actinobacteria-mediated nanoparticles in the field of nanomedicine.

Keywords: Nanomedicine, antimicrobial therapy, actinobacteria, MDR, nanoparticles, drug resistance.

[1]
Khan ZUH, Khan A, Chen Y, et al. Biomedical applications of green synthesized Nobel metal nanoparticles. J Photochem Photobiol B 2017; 173: 150-64.
[http://dx.doi.org/10.1016/j.jphotobiol.2017.05.034] [PMID: 28582711]
[2]
Torres-Sangiao E, Holban AM, Gestal MC. Advanced nanobiomaterials: Vaccines, diagnosis and treatment of infectious diseases. Molecules 2016; 21(7)E867
[http://dx.doi.org/10.3390/molecules21070867] [PMID: 27376260]
[3]
Panigrahi S, Kundu S, Ghosh S, Nath S, Pal T. General method of synthesis for metal nanoparticles. J Nanopart Res 2004; 6(4): 411-4.
[http://dx.doi.org/10.1007/s11051-004-6575-2]
[4]
Rani A, Reddy R, Sharma U, Mukherjee P, Mishra P, Kuila A. A review on the progress of nanostructure materials for energy harnessing and environmental remediation. J Nanostructure Chem 2018; 8(3): 255-91.
[http://dx.doi.org/10.1007/s40097-018-0278-1]
[5]
Dhand C, Dwivedi N, Loh XJ, Jie Ying AN, Verma NK, Beuerman RW. Methods and strategies for the synthesis of diverse nanoparticles and their applications: A comprehensive overview. RSC Advances 2015; 5(127): 105003-37.
[http://dx.doi.org/10.1039/C5RA19388E]
[6]
Li Y, Wang Y, Huang G, Gao J. Cooperativity principles in self-assembled nanomedicine. Chem Rev 2018; 118(11): 5359-91.
[http://dx.doi.org/10.1021/acs.chemrev.8b00195] [PMID: 29693377]
[7]
Reverberi AP, Kuznetsov NT, Meshalkin VP, Salerno M, Fabiano B. Systematical analysis of chemical methods in metal nanoparticles synthesis. Theor Found Chem Eng 2016; 50(1): 59-66.
[http://dx.doi.org/10.1134/S0040579516010127]
[8]
Makarov VV, Love AJ, Sinitsyna OV, et al. “Green” nanotechnologies: Synthesis of metal nanoparticles using plants. Acta Naturae 2014; 6(1): 35-44.
[PMID: 24772325]
[9]
Das RK, Pachapur VL, Lonappan L, Naghdi M, Pulicharla R, Maiti S. Biological synthesis of metallic nanoparticles: Plants, animals and microbial aspects. Nanotech Env Eng 2017; 2: 18.
[http://dx.doi.org/10.1007/s41204-017-0029-4]
[10]
Ali A, Zafar H, Zia M, et al. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl 2016; 9: 49-67.
[http://dx.doi.org/10.2147/NSA.S99986] [PMID: 27578966]
[11]
Thota S, Crans DC. Metal nanoparticles : Synthesis and applications in pharmaceutical sciences. John Wiley & Sons 2018.
[http://dx.doi.org/10.1002/9783527807093]
[12]
Cabral H, Miyata K, Osada K, Kataoka K. Block Copolymer Micelles in Nanomedicine Applications. Chem Rev 2018; 118(14): 6844-92.
[http://dx.doi.org/10.1021/acs.chemrev.8b00199] [PMID: 29957926]
[13]
Sivasankar P, Seedevi P, Poongodi S, et al. Characterization, antimicrobial and antioxidant property of exopolysaccharide mediated silver nanoparticles synthesized by Streptomyces violaceus MM72. Carbohydr Polym 2018; 181: 752-9.
[http://dx.doi.org/10.1016/j.carbpol.2017.11.082] [PMID: 29254032]
[14]
Nayantara KP. Biosynthesis of nanoparticles using eco-friendly factories and their role in plant pathogenicity: A review. Biotechnology Research and Innovation 2018; 2(1): 63-73.
[http://dx.doi.org/10.1016/j.biori.2018.09.003]
[15]
Puja P, Kumar P. A perspective on biogenic synthesis of platinum nanoparticles and their biomedical applications. Spectrochim Acta A Mol Biomol Spectrosc 2019; 211: 94-9.
[http://dx.doi.org/10.1016/j.saa.2018.11.047] [PMID: 30521998]
[16]
Rajasekhar C, Kanchi S. Green Nanomaterials for Clean Environment Handb Ecomater. Cham: Springer International Publishing 2018; pp. 1-18.
[17]
Quesada-González D, Merkoçi A. Nanomaterial-based devices for point-of-care diagnostic applications. Chem Soc Rev 2018; 47(13): 4697-709.
[http://dx.doi.org/10.1039/C7CS00837F] [PMID: 29770813]
[18]
Ma D-L, Wu C, Tang W, Gupta A-R, Lee F-W, Li G, et al. Recent advances in iridium(iii) complex-assisted nanomaterials for biological applications. J Mater Chem B Mater Biol Med 2018; 6: 537-44.
[http://dx.doi.org/10.1039/C7TB02859H]
[19]
Nabila MI, Kannabiran K. Biosynthesis, characterization and antibacterial activity of copper oxide nanoparticles (CuO NPs) from actinomycetes. Biocatal Agric Biotechnol 2018; 15: 56-62.
[http://dx.doi.org/10.1016/j.bcab.2018.05.011]
[20]
Tapan KG, Bijaya G. Polysaccharide based Nano-Biocarrier in Drug Delivery. CRC PRESS 2018.
[http://dx.doi.org/10.1201/9780429449437]
[21]
Sharma G, Kumar D, Kumar A, et al. Revolution from monometallic to trimetallic nanoparticle composites, various synthesis methods and their applications: A review. Mater Sci Eng C 2017; 71: 1216-30.
[http://dx.doi.org/10.1016/j.msec.2016.11.002] [PMID: 27987678]
[22]
Saif S, Tahir A, Chen Y, Saif S, Tahir A, Chen Y. Green Synthesis of Iron Nanoparticles and Their Environmental Applications and Implications. Nanomaterials (Basel) 2016; 6(11): 209.
[http://dx.doi.org/10.3390/nano6110209] [PMID: 28335338]
[23]
Pandey S, Madhuree K, Satyendra PS, et al. Bioremediation via Nanoparticles: An Innovative Microbial Approach Handb Res Uncovering New Methods Ecosyst Manag through Bioremediation. IGI Global 2018; pp. 491-515.
[24]
Hulkoti NI, Taranath TC. Biosynthesis of nanoparticles using microbes- a review. Colloids Surf B Biointerfaces 2014; 121: 474-83.
[http://dx.doi.org/10.1016/j.colsurfb.2014.05.027] [PMID: 25001188]
[25]
Singh P, Kim Y-J, Zhang D, Yang D-C. Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol 2016; 34(7): 588-99.
[http://dx.doi.org/10.1016/j.tibtech.2016.02.006] [PMID: 26944794]
[26]
Guo M, Li W, Yang F, Liu H. Controllable biosynthesis of gold nanoparticles from a Eucommia ulmoides bark aqueous extract. Spectrochim Acta A Mol Biomol Spectrosc 2015; 142: 73-9.
[http://dx.doi.org/10.1016/j.saa.2015.01.109] [PMID: 25699695]
[27]
Ahmed S, Ahmad M, Swami BL, Ikram S. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. J Adv Res 2016; 7(1): 17-28.
[http://dx.doi.org/10.1016/j.jare.2015.02.007] [PMID: 26843966]
[28]
Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules 2015; 20(5): 8856-74.
[http://dx.doi.org/10.3390/molecules20058856] [PMID: 25993417]
[29]
Durán N, Durán M, de Jesus MB, Seabra AB, Fávaro WJ, Nakazato G. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. Nanomedicine (Lond) 2016; 12(3): 789-99.
[http://dx.doi.org/10.1016/j.nano.2015.11.016] [PMID: 26724539]
[30]
Haider A, Kang I-K. Preparation of silver nanoparticles and their industrial and biomedical applications: A comprehensive review. Adv Mater Sci Eng 2015; 2015: 1-16.
[http://dx.doi.org/10.1155/2015/165257]
[31]
Velusamy P, Kumar GV, Jeyanthi V, Das J, Pachaiappan R. Bio-inspired green nanoparticles: Synthesis, mechanism, and antibacterial application. Toxicol Res 2016; 32(2): 95-102.
[http://dx.doi.org/10.5487/TR.2016.32.2.095] [PMID: 27123159]
[32]
Das VL, Thomas R, Varghese RT, Soniya E V, Mathew J, Radhakrishnan EK. Extracellular synthesis of silver nanoparticles by the Bacillus strain CS 11 isolated from industrialized area. 3 Biotech 2014; 4(2): 121-26.
[33]
Cecchin I, Reddy KR, Thomé A, Tessaro EF, Schnaid F. Nanobioremediation: Integration of nanoparticles and bioremediation for sustainable remediation of chlorinated organic contaminants in soils. Int Biodeterior Biodegradation 2017; 119: 419-28.
[http://dx.doi.org/10.1016/j.ibiod.2016.09.027]
[34]
Rani M, Shanker U, Jassal V. Recent strategies for removal and degradation of persistent & toxic organochlorine pesticides using nanoparticles: A review. J Environ Manage 2017; 190: 208-22.
[http://dx.doi.org/10.1016/j.jenvman.2016.12.068] [PMID: 28056354]
[35]
Alabresm A, Chen YP, Decho AW, Lead J. A novel method for the synergistic remediation of oil-water mixtures using nanoparticles and oil-degrading bacteria. Sci Total Environ 2018; 630: 1292-7.
[http://dx.doi.org/10.1016/j.scitotenv.2018.02.277] [PMID: 29554750]
[36]
Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: A developing country-perspective. Front Microbiol 2016; 7: 1881.
[http://dx.doi.org/10.3389/fmicb.2016.01881] [PMID: 27933044]
[37]
Sharma D, Patel RP, Zaidi STR, Sarker MMR, Lean QY, Ming LC. Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries. Front Pharmacol 2017; 8: 546.
[http://dx.doi.org/10.3389/fphar.2017.00546] [PMID: 28871228]
[38]
Panigrahi P, Chandel DS, Hansen NI, et al. Neonatal sepsis in rural India: Timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting. J Perinatol 2017; 37(8): 911-21.
[http://dx.doi.org/10.1038/jp.2017.67] [PMID: 28492525]
[39]
Ahmed MF, Feroz M. A Survey on Drug Dispensing Patterns by Drug Retailers in Bangladesh 2015.
[40]
van Spijk JN, Schmitt S, Schoster A. Infections caused by multidrug-resistant bacteria in an equine hospital (2012-2015). Equine Vet Educ 2017; 1-6.
[http://dx.doi.org/10.1111/eve.12837]
[41]
Dat VQ, Vu HN. Nguyen The H, et al.Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: Aetiology, drug resistance, and treatment outcome. BMC Infect Dis 2017; 17(1): 493.
[http://dx.doi.org/10.1186/s12879-017-2582-7] [PMID: 28701159]
[42]
Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med 2017; 43(9): 1187-97.
[http://dx.doi.org/10.1007/s00134-017-4682-7] [PMID: 28160023]
[43]
Thaden JT, Li Y, Ruffin F, et al. Increased costs associated with bloodstream infections caused by multidrug-resistant gram-negative bacteria are due primarily to patients with hospital-acquired infections. Antimicrob Agents Chemother 2017; 61(3): e01709-16.
[http://dx.doi.org/10.1128/AAC.01709-16] [PMID: 27993852]
[44]
Marks SM, Mase SR, Morris SB. Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis. Clin Infect Dis 2017; 64(12): 1670-7.
[http://dx.doi.org/10.1093/cid/cix208] [PMID: 28329197]
[45]
Oh P, Pascopella L, Barry PM, Flood JM. A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015. BMC Res Notes 2017; 10(1): 434.
[http://dx.doi.org/10.1186/s13104-017-2754-y] [PMID: 28854957]
[46]
Salgado Yepez E, Bovera MM, Rosenthal VD, et al. Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium’s findings. World J Biol Chem 2017; 8(1): 95-101.
[http://dx.doi.org/10.4331/wjbc.v8.i1.95] [PMID: 28289522]
[47]
Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014. Infect Control Hosp Epidemiol 2016; 37(11): 1288-301.
[http://dx.doi.org/10.1017/ice.2016.174] [PMID: 27573805]
[48]
Hagras M, Mohammad H, Mandour MS, et al. Investigating the antibacterial activity of biphenylthiazoles against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA). J Med Chem 2017; 60(9): 4074-85.
[http://dx.doi.org/10.1021/acs.jmedchem.7b00392] [PMID: 28436655]
[49]
Arnold FW, Beavin LA. Increased methicillin-resistant Staphylococcus aureus septicemia and illicit intravenous drug use in the South. Clin Infect Dis 2018; 67(2): 319-20.
[http://dx.doi.org/10.1093/cid/ciy116] [PMID: 29462274]
[50]
Martín-Loeches I, Diaz E, Vallés J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care 2014; 20(5): 516-24.
[http://dx.doi.org/10.1097/MCC.0000000000000124] [PMID: 25188366]
[51]
Evans SR, Hujer AM, Jiang H, et al. Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against Acinetobacter spp. in PRIMERS III. J Clin Microbiol 2016; 55(1): 134-44.
[http://dx.doi.org/10.1128/JCM.01524-16] [PMID: 27795336]
[52]
Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis 2018; 18(1): 56.
[http://dx.doi.org/10.1186/s12879-018-2960-9] [PMID: 29373965]
[53]
Heinz E, Ejaz H, Bartholdson-Scott J, Wang N, Guanjaran S, Pickard D. Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing Klebsiella pneumoniae and K. quasipneumoniae highlights different evolutionary mechanisms. bioRxiv 2018.283291
[54]
Hanif M, Hartinger CG. Anticancer metallodrugs: Where is the next cisplatin? Future Med Chem 2018; 10(6): 615-7.
[http://dx.doi.org/10.4155/fmc-2017-0317] [PMID: 29411994]
[55]
Savic M, Årdal C. A grant framework as a push incentive to stimulate research and development of new antibiotics 2018; 46: 9-24.
[56]
Barancheshme F, Munir M. Strategies to combat antibiotic resistance in the wastewater treatment plants. Front Microbiol 2018; 8: 2603.
[http://dx.doi.org/10.3389/fmicb.2017.02603] [PMID: 29387043]
[57]
Kora AJ, Sashidhar RB. Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cytotoxicity and its mode of action. Arab J Chem 2018; 11(3): 313-23.
[http://dx.doi.org/10.1016/j.arabjc.2014.10.036]
[58]
Chien C-S, Lin C-J, Ko C-J, Tseng S-P, Shih C-J. Antibacterial activity of silver nanoparticles (AgNP) confined to mesostructured silica against methicillin-resistant Staphylococcus aureus (MRSA). J Alloys Compd 2018; 747: 1-7.
[http://dx.doi.org/10.1016/j.jallcom.2018.02.334]
[59]
Silvan JM, Zorraquin-Peña I, Gonzalez de Llano D, Moreno-Arribas MV, Martinez-Rodriguez AJ. Antibacterial Activity of Glutathione-Stabilized Silver Nanoparticles Against Campylobacter Multidrug-Resistant Strains. Front Microbiol 2018; 9: 458.
[http://dx.doi.org/10.3389/fmicb.2018.00458] [PMID: 29615993]
[60]
Gadkari RR, Ali SW, Alagirusamy R, Das A. Silver nanoparticles in water purification: Opportunities and challenges mod age environ probl their remediat. Cham: Springer International Publishing 2018; pp. 229-37.
[http://dx.doi.org/10.1007/978-3-319-64501-8_13]
[61]
Praveena SM, Karuppiah K, Than LTL. Potential of cellulose paper coated with silver nanoparticles: A benign option for emergency drinking water filter. Cellulose 2018; 25(4): 2647-58.
[http://dx.doi.org/10.1007/s10570-018-1747-x]
[62]
Haider A, Haider S, Kang I-K, et al. A novel use of cellulose based filter paper containing silver nanoparticles for its potential application as wound dressing agent. Int J Biol Macromol 2018; 108: 455-61.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.12.022] [PMID: 29222019]
[63]
Wu C-N, Fuh S-C, Lin S-P, et al. TEMPO-oxidized bacterial cellulose pellicle with silver nanoparticles for wound dressing. Biomacromolecules 2018; 19(2): 544-54.
[http://dx.doi.org/10.1021/acs.biomac.7b01660] [PMID: 29334612]
[64]
Zhang H, Peng M, Cheng T, Zhao P, Qiu L, Zhou J. Silver nanoparticles-doped collagen-alginate antimicrobial biocomposite as potential wound dressing. J Mater Sci 2018; 53(21): 14944-52.
[http://dx.doi.org/10.1007/s10853-018-2710-9]
[65]
Duran R, Bielen A, Paradžik T, et al. Exploring Actinobacteria assemblages in coastal marine sediments under contrasted Human influences in the West Istria Sea, Croatia. Environ Sci Pollut Res Int 2015; 22(20): 15215-29.
[http://dx.doi.org/10.1007/s11356-015-4240-1] [PMID: 25712885]
[66]
Sarmiento-Vizcaíno A, Braña AF, González V, et al. Atmospheric dispersal of bioactive streptomyces albidoflavus strains among terrestrial and marine environments. Microb Ecol 2016; 71(2): 375-86.
[http://dx.doi.org/10.1007/s00248-015-0654-z] [PMID: 26224165]
[67]
Gobalakrishnan R, Sivasankar P, Sivakumar K. Marine actinobacteria: A concise account for young researchers 2018.
[68]
Panda AK, Bisht SS, Rana M, De Mandal S, Kumar NS. Biotechnological Potential of Thermophilic Actinobacteria Associated With Hot Springs 2018.
[http://dx.doi.org/10.1016/B978-0-444-63994-3.00010-2]
[69]
Goodfellow M, Nouioui I, Sanderson R, Xie F, Bull AT. Rare taxa and dark microbial matter: Novel bioactive actinobacteria abound in Atacama Desert soils. Antonie van Leeuwenhoek 2018; 111(8): 1315-32.
[http://dx.doi.org/10.1007/s10482-018-1088-7] [PMID: 29721711]
[70]
Hoskisson PA, Fernández-Martínez LT. Regulation of specialised metabolites in Actinobacteria - expanding the paradigms. Environ Microbiol Rep 2018; 10(3): 231-8.
[http://dx.doi.org/10.1111/1758-2229.12629] [PMID: 29457705]
[71]
Lee L-H, Zainal N, Azman A-S, et al. Diversity and antimicrobial activities of actinobacteria isolated from tropical mangrove sediments in Malaysia. ScientificWorldJournal 2014; 2014698178
[http://dx.doi.org/10.1155/2014/698178] [PMID: 25162061]
[72]
Bhattacharya SS, Yadav JS. Microbial P450 enzymes in bioremediation and drug discovery: Emerging potentials and challenges. Curr Protein Pept Sci 2018; 19(1): 75-86.
[PMID: 27875967]
[73]
Spasic J, Mandic M, Djokic L, Nikodinovic-Runic J. Streptomyces spp. in the biocatalysis toolbox. Appl Microbiol Biotechnol 2018; 102(8): 3513-36.
[http://dx.doi.org/10.1007/s00253-018-8884-x] [PMID: 29502181]
[74]
McSorley FR, Johnson JW, Wright GD. Natural products in antibiotic discovery antimicrob resist 21st century. Cham: Springer International Publishing 2018; pp. 533-62.
[75]
Norouzi H, Danesh A, Mohseni M, Rabbani Khorasgani M. Marine actinomycetes with probiotic potential and bioactivity against multidrug-resistant bacteria. Int J Mol Cell Med 2018; 7(1): 44-52.
[PMID: 30234072]
[76]
El-Moslamy SH. Bioprocessing strategies for cost-effective large-scale biogenic synthesis of nano-MgO from endophytic Streptomyces coelicolor strain E72 as an anti-multidrug-resistant pathogens agent. Sci Rep 2018; 8(1): 3820.
[http://dx.doi.org/10.1038/s41598-018-22134-x] [PMID: 29491452]
[77]
Javaid A, Oloketuyi SF, Khan MM, Khan F. Diversity of bacterial synthesis of silver nanoparticles. Bionanoscience 2018; 8(1): 43-59.
[http://dx.doi.org/10.1007/s12668-017-0496-x]
[78]
Manimaran M, Kannabiran K. Actinomycetes-mediated biogenic synthesis of metal and metal oxide nanoparticles: progress and challenges. Lett Appl Microbiol 2017; 64(6): 401-8.
[http://dx.doi.org/10.1111/lam.12730] [PMID: 28267874]
[79]
Ranjitha VR, Rai VR. Actinomycetes mediated synthesis of gold nanoparticles from the culture supernatant of Streptomyces griseoruber with special reference to catalytic activity. 3 Biotech 2017. 7: 299
[80]
Składanowski M, Wypij M, Laskowski D, Golińska P, Dahm H, Rai M. Silver and gold nanoparticles synthesized from Streptomyces sp. isolated from acid forest soil with special reference to its antibacterial activity against pathogens. J Cluster Sci 2017; 28(1): 59-79.
[http://dx.doi.org/10.1007/s10876-016-1043-6]
[81]
Caracciolo G, Farokhzad OC, Mahmoudi M. Biological identity of nanoparticles in vivo: Clinical implications of the protein corona. Trends Biotechnol 2017; 35(3): 257-64.
[http://dx.doi.org/10.1016/j.tibtech.2016.08.011] [PMID: 27663778]
[82]
Mohammed L, Gomaa HG, Ragab D, Zhu J. Magnetic nanoparticles for environmental and biomedical applications: A review. Particuology 2017; 30: 1-14.
[http://dx.doi.org/10.1016/j.partic.2016.06.001]
[83]
Patra S, Mukherjee S, Barui AK, Ganguly A, Sreedhar B, Patra CR. Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Mater Sci Eng C 2015; 53: 298-309.
[http://dx.doi.org/10.1016/j.msec.2015.04.048] [PMID: 26042718]
[84]
Benelli G, Lukehart CM. Special issue: Applications of green-synthesized nanoparticles in pharmacology, parasitology and entomology. J Cluster Sci 2017; 28(1): 1-2.
[http://dx.doi.org/10.1007/s10876-017-1165-5]
[85]
Mirzaei H, Darroudi M. Zinc oxide nanoparticles: Biological synthesis and biomedical applications. Ceram Int 2017; 43(1): 907-14.
[http://dx.doi.org/10.1016/j.ceramint.2016.10.051]
[86]
Dhall A, Self W, Dhall A, Self W. Cerium Oxide Nanoparticles: A Brief Review of Their Synthesis Methods and Biomedical Applications. Antioxidants 2018; 7(8)E97
[http://dx.doi.org/10.3390/antiox7080097] [PMID: 30042320]
[87]
Naitō M, Yokoyama T, Hosokawa K, Nogi K, Eds. Nanoparticle technology handbook. 3rd ed. Elsevier 2018.
[88]
Rafique M, Sadaf I, Rafique MS, Tahir MB. A review on green synthesis of silver nanoparticles and their applications. Artif Cells Nanomed Biotechnol 2017; 45(7): 1272-91.
[http://dx.doi.org/10.1080/21691401.2016.1241792] [PMID: 27825269]
[89]
Li S, Duan Y, Li R, Wang X. Intracellular and extracellular biosynthesis of antibacterial silver nanoparticles by using Pseudomonas aeruginosa. J Nanosci Nanotechnol 2017; 17(12): 9186-91.
[http://dx.doi.org/10.1166/jnn.2017.13920]
[90]
Hu G, Liang G, Zhang W, Jin W, Zhang Y, Chen Q. Silver nanoparticles with low cytotoxicity: Controlled synthesis and surface modification with histidine. J Mater Sci 2018; 53(7): 4768-80.
[http://dx.doi.org/10.1007/s10853-017-1940-6]
[91]
Morita M, Tachikawa T, Seino S, Tanaka K, Majima T. Controlled synthesis of gold nanoparticles on fluorescent nanodiamond via electron-beam-induced reduction method for dual-modal optical and electron bioimaging. ACS Appl Nano Mater 2018; 1(1): 355-63.
[http://dx.doi.org/10.1021/acsanm.7b00213]
[92]
Manivasagan P, Venkatesan J, Sivakumar K, Kim S-K. Actinobacteria mediated synthesis of nanoparticles and their biological properties: A review. Crit Rev Microbiol 2016; 42(2): 209-21.
[PMID: 25430521]
[93]
Manikprabhu D, Cheng J, Chen W, et al. Sunlight mediated synthesis of silver nanoparticles by a novel actinobacterium (Sinomonas mesophila MPKL 26) and its antimicrobial activity against multi drug resistant Staphylococcus aureus. J Photochem Photobiol B 2016; 158: 202-5.
[http://dx.doi.org/10.1016/j.jphotobiol.2016.01.018] [PMID: 26982503]
[94]
Sadhasivam S, Shanmugam P, Yun K. Biosynthesis of silver nanoparticles by Streptomyces hygroscopicus and antimicrobial activity against medically important pathogenic microorganisms. Colloids Surf B Biointerfaces 2010; 81(1): 358-62.
[http://dx.doi.org/10.1016/j.colsurfb.2010.07.036] [PMID: 20705438]
[95]
Sholkamy EN, Ahamd MS, Yasser MM, Eslam N. Anti-microbiological activities of bio-synthesized silver Nano-stars by Saccharopolyspora hirsuta. Saudi J Biol Sci 2019; 26(1): 195-200.
[http://dx.doi.org/10.1016/j.sjbs.2018.02.020] [PMID: 30627051]
[96]
Saravana Kumar P, Balachandran C, Duraipandiyan V, Ramasamy D, Ignacimuthu S, Al-Dhabi NA. Extracellular biosynthesis of silver nanoparticle using Streptomyces sp. 09 PBT 005 and its antibacterial and cytotoxic properties. Appl Nanosci 2015; 5(2): 169-80.
[http://dx.doi.org/10.1007/s13204-014-0304-7]
[97]
Adiguzel AO, Adiguzel SK, Mazmanci B, Tunçer M, Mazmanci MA. Silver nanoparticle biosynthesis from newly isolated streptomyces genus from soil. Mater Res Express 2018; 5(4)
[http://dx.doi.org/10.1088/2053-1591/aab861]
[98]
Könen-Adıgüzel S, Adıgüzel AO, Ay H, Alpdoğan S, Şahin N, Çaputçu A. Genotoxic, cytotoxic, antimicrobial and antioxidant properties of gold nanoparticles synthesized by Nocardia sp. GTS18 using response surface methodology. Mater Res Express 2018.5115402
[http://dx.doi.org/10.1088/2053-1591/aadcc4]
[99]
Abirami M, Kannabiran K. Streptomyces ghanaensis VITHM1 mediated green synthesis of silver nanoparticles: Mechanism and biological applications. Front Chem Sci Eng 2016; 10(4): 542-51.
[http://dx.doi.org/10.1007/s11705-016-1599-6]
[100]
Wypij M, Świecimska M, Dahm H, Rai M, Golinska P. Controllable biosynthesis of silver nanoparticles using actinobacterial strains. Green Processing Synthesis 2019; 8(1): 207-14.
[http://dx.doi.org/10.1515/gps-2018-0070]
[101]
Wypij M, Golinska P, Dahm H, Rai M. Actinobacterial-mediated synthesis of silver nanoparticles and their activity against pathogenic bacteria. IET Nanobiotechnol 2017; 11(3): 336-42.
[http://dx.doi.org/10.1049/iet-nbt.2016.0112] [PMID: 28476992]
[102]
Vijayabharathi R, Sathya A, Gopalakrishnan S. Extracellular biosynthesis of silver nanoparticles using Streptomyces griseoplanus SAI-25 and its antifungal activity against Macrophomina phaseolina, the charcoal rot pathogen of sorghum. Biocatal Agric Biotechnol 2018; 14: 166-71.
[http://dx.doi.org/10.1016/j.bcab.2018.03.006]
[103]
Sholkamy EN, Ahamd MS, Yasser MM, Eslam N. Anti-microbiological activities of bio-synthesized silver Nano-stars by Saccharopolyspora hirsuta. Saudi J Biol Sci 2019; 26(1): 195-200.
[http://dx.doi.org/10.1016/j.sjbs.2018.02.020] [PMID: 30627051]
[104]
Vinay Gopal J, Thenmozhi M, Kannabiran K, Rajakumar G, Velayutham K, Rahuman AA. Actinobacteria mediated synthesis of gold nanoparticles using Streptomyces sp. VITDDK3 and its antifungal activity. Mater Lett 2013; 93: 360-2.
[http://dx.doi.org/10.1016/j.matlet.2012.11.125]
[105]
Wypij M, Golinska P, Dahm H, Rai M. Actinobacterial-mediated synthesis of silver nanoparticles and their activity against pathogenic bacteria. IET Nanobiotechnol 2017; 11(3): 336-42.
[http://dx.doi.org/10.1049/iet-nbt.2016.0112] [PMID: 28476992]
[106]
Manivasagan P, Alam MS, Kang K-H, Kwak M, Kim S-K. Extracellular synthesis of gold bionanoparticles by Nocardiopsis sp. and evaluation of its antimicrobial, antioxidant and cytotoxic activities. Bioprocess Biosyst Eng 2015; 38(6): 1167-77.
[http://dx.doi.org/10.1007/s00449-015-1358-y] [PMID: 25645365]
[107]
Shanmugasundaram T, Balagurunathan R. Bio-medically active zinc oxide nanoparticles synthesized by using extremophilic actinobacterium, Streptomyces sp. (MA30) and its characterization. Artif Cells Nanomed Biotechnol 2017; 45(8): 1521-9.
[http://dx.doi.org/10.1080/21691401.2016.1260577] [PMID: 27903085]
[108]
Ramya S, Shanmugasundaram T, Balagurunathan R. Biomedical potential of actinobacterially synthesized selenium nanoparticles with special reference to anti-biofilm, anti-oxidant, wound healing, cytotoxic and anti-viral activities. J Trace Elem Med Biol 2015; 32: 30-9.
[http://dx.doi.org/10.1016/j.jtemb.2015.05.005] [PMID: 26302909]
[109]
Rasool U, Hemalatha S. Marine endophytic actinomycetes assisted synthesis of copper nanoparticles (CuNPs): Characterization and antibacterial efficacy against human pathogens. Mater Lett 2017; 194: 176-80.
[http://dx.doi.org/10.1016/j.matlet.2017.02.055]
[110]
Shaaban M, El-Mahdy AM. Biosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate Streptomyces enissocaesilis. IET Nanobiotechnol 2018; 12(6): 741-7.
[http://dx.doi.org/10.1049/iet-nbt.2017.0213] [PMID: 30104447]
[111]
Abd-Elnaby HM, Abo-Elala GM, Abdel-Raouf UM, Hamed MM. Antibacterial and anticancer activity of extracellular synthesized silver nanoparticles from marine Streptomyces rochei MHM13. Egypt J Aquat Res 2016; 42(3): 301-12.
[http://dx.doi.org/10.1016/j.ejar.2016.05.004]
[112]
Wen Z, Liu J, Li J. Core/shell Pt/C nanoparticles embedded in mesoporous carbon as a methanol-tolerant cathode catalyst in direct methanol fuel cells. Adv Mater 2008; 20(4): 743-7.
[http://dx.doi.org/10.1002/adma.200701578]
[113]
Kang B, Mackey MA, El-Sayed MA. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 2010; 132(5): 1517-9.
[http://dx.doi.org/10.1021/ja9102698] [PMID: 20085324]
[114]
Shanmugasundaram T, Balagurunathan R. Bio-directed synthesis, structural characterisation of platinum based metal nanocomposites (Pt/Ag, Pt/Au, Pt/Ag/Au) and their biomedical applications. Mater Res Express 2018; 5(9)095402
[http://dx.doi.org/10.1088/2053-1591/aad7e0]
[115]
Ratnakomala S, Ratnakomala S. Antimicrobial activity of selenium nanoparticles synthesized by actinomycetes isolated from Lombok island soil samples. J Kim Terap Indones 2018; 20(1): 8-15.
[http://dx.doi.org/10.14203/jkti.v20i1.374]
[116]
Dagmar H, Kristyna C, Pavel K, Vojtech A, Rene K. Selenium nanoparticles and evaluation of their antimicrobial activity on bacterial isolates obtained from clinical specimens 2015.
[117]
Railean-Plugaru V, Pomastowski P, Wypij M, et al. Study of silver nanoparticles synthesized by acidophilic strain of Actinobacteria isolated from the of Picea sitchensis forest soil. J Appl Microbiol 2016; 120(5): 1250-63.
[http://dx.doi.org/10.1111/jam.13093] [PMID: 26864807]
[118]
Anasane N, Golińska P, Wypij M, Rathod D, Dahm H, Rai M. Acidophilic actinobacteria synthesised silver nanoparticles showed remarkable activity against fungi-causing superficial mycoses in humans. Mycoses 2016; 59(3): 157-66.
[http://dx.doi.org/10.1111/myc.12445] [PMID: 26671603]
[119]
Wypij M, Czarnecka J, Dahm H, Rai M, Golinska P. Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses. J Basic Microbiol 2017; 57(9): 793-800.
[http://dx.doi.org/10.1002/jobm.201700121] [PMID: 28670763]
[120]
Buszewski B, Railean-Plugaru V, Pomastowski P, et al. Antimicrobial activity of biosilver nanoparticles produced by a novel Streptacidiphilus durhamensis strain. J Microbiol Immunol Infect 2018; 51(1): 45-54.
[http://dx.doi.org/10.1016/j.jmii.2016.03.002] [PMID: 27103501]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 24
Year: 2019
Published on: 02 October, 2019
Page: [2626 - 2636]
Pages: 11
DOI: 10.2174/1381612825666190709221710
Price: $65

Article Metrics

PDF: 27
HTML: 2